Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Bronchoprotective mechanisms for specialized pro-resolving mediators in the resolution of lung inflammation

Full text
Author(s):
Duvall, Melody G. [1, 2] ; Bruggemann, Thayse R. [1, 3] ; Levy, Bruce D. [1]
Total Authors: 3
Affiliation:
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Boston, MA 02115 - USA
[2] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Div Crit Care Med, Boston, MA 02115 - USA
[3] Univ Sao Paulo, Sch Med, Lab Expt Therapeut LIM 20, Sao Paulo - Brazil
Total Affiliations: 3
Document type: Review article
Source: MOLECULAR ASPECTS OF MEDICINE; v. 58, p. 44-56, DEC 2017.
Web of Science Citations: 8
Abstract

Bronchi are exposed daily to irritants, microbes and allergens as well as extremes of temperature and acid. The airway mucosal epithelium plays a pivotal role as a sentinel, releasing alarmins when danger is encountered. To maintain homeostasis, an elaborate counter-regulatory network of signals and cellular effector mechanisms are needed. Specialized pro-resolving mediators (SPMs) are chemical mediators that enact resolution programs in response to injury, infection or allergy. SPMs are enzymatically derived from essential polyunsaturated fatty acids with potent cell-type specific immunoresolvent properties. SPMs signal by engaging cell-based receptors to turn off acute inflammatory responses and restore tissue homeostasis. Several common lung diseases involving the airways, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF), are characterized by unresolved bronchial inflammation. In preclinical murine models of lung disease, SPMs carry potent bronchoprotective actions. Here, we review cellular and molecular effects for SPM-initiated catabasis in the lung and their human translation. (C) 2017 Elsevier Ltd. All rights reserved. (AU)

FAPESP's process: 15/26048-5 - Analysis of dendritic cell and T cell pathway in a murine model of chronic pulmonary allergic inflammation with exposition to cigarette smoke
Grantee:Thayse Regina Bruggemann
Support Opportunities: Scholarships abroad - Research Internship - Doctorate (Direct)